Fibryga® approved for acquired fibrinogen deficiency in Europe
New clinical data support efficacy of fibrinogen concentrate (fibryga®) in treating acquired fibrinogen deficiency and lead to label extension in Europe Fibrinogen replacement is widely accepted as an approach to managing acquired fibrinogen deficiency (AFD) in patients with critical bleeding, despite a lack of evidence until now from controlled clinical studies. Data from two comparative […]
White Paper – Red Cell Salvage: Current Status
Mark A. Popovsky, MDChief Medical OfficerHaemonetics CorporationBraintree, MA, USA Download article in PDF format Background Intraoperative Red Cell Salvage (RCS) was introduced in the early 1980s and rapidly gained clinical acceptance. Early RCS was done without cell washing, but washed RCS became the standard of care in cardiac surgery and other procedures as its advantage […]
